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Tosh, K., Cheesman, S., Horrocks, P., and Kilbey, B. 1999. Plasmoa DNA duplex (Liu, 1989) . Type I topoisomerases cleave a ing by rotation about the intact strand, whereas type II enisomerase I (PfTopoI) has been examined during the intraerythrocytic zymes cleave both DNA strands and pass an uncut duplex stages of the Plasmodium falciparum life cycle. The promoter is inactive during the early ring stage and becomes active only during the through the gap before resealing it. Class I topisomerases later trophozoite and schizont stages. The PfTOP1 transcript starts to have been implicated in several cellular activities. These accumulate in the trophozoite stage parasite, decreasing again in the include DNA replication (Yang et al. 1987) , transcription schizont stage. Using both stage-specific Western analysis and immuno- (Gilmour and Elgin 1987; Brill et al. 1987 and Schaak fluorescent assays we show that PfTopoI is present at low levels in et al. 1990) , recombination (Bullock et al. 1985) , and the rings and accumulates to approximately equal levels in the trophozoite and schizont stages. Experiments to determine the activity of PfTopoI, maintenance of chromosome structure (Maul et al. 1986) . using a topoisomerase I relaxation assay, show that there is a low level More recently, the enzyme has also been demonstrated to of PfTopoI activity in both ring and trophozoite stages, but activity exhibit a phosphotransferase activity associated with sarcoincreases dramatically in the schizont stage. The PfTopoI activity can plasmic reticulum (SR) protein splicing factors (Rossi et al. be inhibited by treatment with specific antiserum and by the type I topoisomerase-specific inhibitor camptothecin. ᭧ 1999 Academic Press 1996) and there is speculation that it may play a role in
Index Descriptors and Abbreviations: Plasmodium falciparum;
DNA repair through its association with p53 (Gobert et al.
camptothecin; kb(s), kilobase(s); MOPS, morpholinepropanesulfonic 1996). The roles for topoisomerase I have been sought in acid; PCR, polymerase chain reaction; PfPCNA, P. falciparum proliferpart by determining the relative level of the protein throughating cell nuclear antigen; PfTopoI, P. falciparum topoisomerase I; out the cell cycle and its distribution within the cell. The PfTOP1, the gene encoding PfTopoI.
enzyme is primarily located within the nucleus and is particularly concentrated in regions where transcription is taking place (Javaherian and Liu 1983; Muller et al. 1985) . Topo-INTRODUCTION isomerase I activity appears to be linked to DNA replication. Its levels increase in proliferating mouse cells both in vitro Topoisomerases alter the topological state of DNA by and in vivo (Tricoli et al. 1985) , rising gradually during the catalysing the breaking and rejoining of DNA strands within G1 phase, followed by a sharp increase on entry into the S phase, with maximum activity being found during mid S parasites using the acidified guanidine isothiocyanate method (Chomthe activity of topoisomerase I. The correlation between the developmental regulation of Hybond C (Amersham) using standard protocols. An anti-peptide antiexpression and action of PfTopoI and its role during schizogbody was raised in rabbits against the peptide sequence SKLINYLD-PRISVAC, which includes the active site tyrosine of the somatic topoony is considered. Finally, the inhibition of PfTopoI activity isomerase I sequence from Xenopus laevis (Panditt et al. 1996) , and in vitro by the eukaryotic topoisomerase I-specific inhibitor was kindly supplied by Dan Bogenhagen, Stony Brook, New York.
camptothecin is shown.
Preimmune serum from the same rabbit was also supplied. The membranes were blocked and probed using the immune and preimmune sera as described by Kilbey et al. (1993) . Immunofluorescence assays (IFA) of acetone-fixed parasites were also carried out using the immune and preimmune sera as described by Cheeseman et al. (1994) .
MATERIALS AND METHODS
Topoisomerase I activity assays. Cell extracts for use in the topoisomerase I activity assays were prepared from 5 ϫ 10 8 parasites from each major developmental stage. The parasites were released and washed with PBS. The parasite pellet was washed twice more in 2 vol Parasite culture. Parasites of the K1 isolate of P. falciparum (Thaithong and Beale 1981) were cultured and synchronised using the methof PBS before being resuspended in an equal volume of topoisomerase I assay buffer (10 mM Tris-HCl, pH 7.9; 1 mM EDTA; 150 mM ods of Trager and Jensen (1976), Zolg et al. (1982) , and Lambros and Vandenberg (1979) . NaCl; 0.1% BSA; 0.1 mM spermidine; 5% glycerol). The parasites were lysed by repeated passage through a 25-gauge needle and the Nuclear run-on analysis. The promoter activity of the gene encoding PfTopoI was analysed in nuclear run-on experiments as described parasite debris was pelleted by microcentrifugation for 2 min. one microliter of the supernatant was used in each topoisomerase assay. earlier (Horrocks et al. 1996) . Nuclei-rich fractions were prepared from synchronised parasites in the ring stage or as a mixture of trophozoite
The parasite extract was incubated for 30 min at 37ЊC, in a 20-l volume containing topoisomerase I assay buffer and 0.5 g of suand schizont stages. The de novo transcripts were radiolabelled and, after isolation, used to probe 1 g of denatured PfTOP1 DNA immobipercoiled pBR322. The reactions were then incubated with 0.5 g/l Proteinase K, 1% SDS, and 100 mM EDTA for 30 min at 50ЊC before lised on a nitrocellulose membrane. DNA from PfPCNA was used in parallel as a control to ensure that radiolabelling of the transcripts was the addition of 2.5 l of stop mix (5% Sarkosyl; 0.0025% bromophenol blue; 25% glycerol). The supercoiled and relaxed forms of plasmid carried out efficiently. The promoter for this gene has already been reported as equally active in both the ring and the mixed trophozoite/ DNA were separated by agarose gel electrophoresis in a 1% gel run in TBE and visualised by ethidium bromide staining and UV illuminaschizont stages (Horrocks et al. 1996) . P. falciparum genomic DNA was used to demonstrate that the general promoter activity in trophozotion of the agarose gel prior to photography. Camptothecin. Camptothecin (Sigma) was prepared as a 100 mM ites and schizonts is greater than that in rings. pBluescript II (SK + ) (Stratagene) was included as a negative control for nonspecific hybridistock solution in DMSO and diluted in distilled water to the required concentration prior to use. sation.
Northern analysis. Total RNA was isolated from synchronised Inactivation of PfTopol activity in parasite extracts. Parasite pellets were prepared from unsynchronised populations of parasites containing a nylon membrane. Further confirmation was obtained by 5 ϫ 10 8 cells as described above. Pellets were quick frozen with dry probing the blot for the 2.5-kb actin I message which is ice and stored at Ϫ70ЊC for up to five days prior to use. Frozen present in all asexual stages of the intraerythrocytic cycle parasites were lysed on ice by addition of topoisomerase I assay buffer (Wesseling et al. 1989) . The 3.8-kb PfTOP1 message appears supplemented with protease inhibitors (1 g/l pepstatin A; 100 g/ l PMSF; 2 g/l leupeptin). Variable amounts of lysate were incuto be present at low levels in the ring stage parasites, at high bated on ice for 30-45 minutes with 1 l of the anti-Xenopus peptide levels in trophozoites, decreasing to barely detectable levels antibody or preimmune serum from the same rabbit. Antibody-treated in schizonts (Fig. 2) . This is similar to the behaviour of extracts were used in topoisomerase I assays following the procedure the 6.6-kb GBP130 message shown here, which reportedly already described.
accumulates only in trophozoites (Lanzer et al. 1992) . It is possible that the faint PfTOP1 and GBP130 signals observed in ring-derived extracts are attributable to the presence of 4% trophozoites in the ring sample from which RNA was RESULTS isolated. The schizont sample appears to have been free of trophozoite contamination.
The accumulation of PfTopoI protein.
Immune serum PfTOP1 promoter activity. Nuclear run-on demonstrates directed against the highly conserved active site of the sothat the PfTOP1 promoter is inactive in ring stage parasites matic TopoI of Xenopus laevis recognises a protein of apbut becomes active at the later developmental stages. Failure proximately 116-kDa parasite extracts. Preimmune serum to detect transcripts in nuclei from ring stage parasites cannot from the same rabbit failed to detect this band. The 116-be attributed to a failure of the labelling step since PCNA kDa protein is barely detectable in extracts from rings but is message is readily detected in the same samples. Overall found at the same higher levels in trophozoites and schizonts transcriptional activity increases during intraerythrocytic de- (Fig. 3) . Indirect immunofluorescence assays with the imvelopment (Horrocks et al. 1996; Lanzer et al. 1993) , as mune and preimmune sera confirmed that the protein is shown by the signal obtained with pooled genomic DNA detectable in parasites fixed at the trophozoite and schizont (Fig. 1) . However, nonspecific labelling can be discounted since the negative control, the plasmid pBluescript II (SK + ), was not recognised by the probe (Fig. 1) .
Accumulation of PfTOP1 transcripts during the asexual intraerythrocytic cycle. Ten micrograms of total RNA isolated from rings, trophozoites, or schizonts was sizefractionated. The gel was stained with ethidium bromide in an attempt to verify that equal amounts of RNA from each stage had been loaded before the RNA was transferred to stages and is localised in the parasite nucleus (data not Further confirmation that the relaxation activity is the shown). Confirmation that the antiserum recognises the acresult of PfTopoI was obtained when it was demonstrated tive site of PfTopoI was obtained when it was shown that that camptothecin, a well-established specific inhibitor of it reacted positively with a PfTopoI fusion protein containing eukaryotic type I topoisomerases, could inhibit relaxation the active site of the enzyme expressed in Escherichia coli activity in asynchronous parasite extracts. A range of camp-(data not shown).
tothecin concentrations were used from 1 to 500 M. The PTopoI activity in parasite extracts and the effects of inhibitory action was greatest at the highest dose of the drug camptothecin. PfTopoI activity in parasite extracts was (Fig. 5) . monitored by assaying their ability to relax supercoiled Inactivation of PfTopoI activity by TopoI antiserum. In pBR322 DNA. In the presence of TopoI, the torsional stress an attempt to obtain further evidence of an interaction beof the supercoiled plasmid is released and the relaxation tween the antiserum and PfTopoI, the effects of the antiserum intermediates may be visualised as a ladder of bands together with totally relaxed plasmid. When there is little or no activity, the plasmid DNA remains in a supercoiled state. An indication of the level of PfTopoI activity during the intraerythrocytic cycle was obtained by performing this assay on extracts derived from the same number of parasites at each developmental stage. Although activity is detectable in extracts from all three developmental stages examined, it appears greatest in schizont extracts (Fig. 4) .
Relaxation of supercoiled plasmid DNA can also be brought about by type II topoisomerases and has been demonstrated for PfTopoII (Cheesman et al. 1998 ). However, TopoII activity was excluded here by omitting Mg 2ϩ ions and ATP from the reaction mix, both of which are necessary for type II topoisomerase activity Stetler et al. 1979) . Direct evidence of the absence of type II topo- not shown).
on the activity of the enzyme were studied using the plasmid assayed directly for TopoI activity in extracts of synchrorelaxation assay. Again, steps were taken to ensure the abnised parasites. TopoI (as distinct from TopoII) activity is sence of TopoII activity in the reaction mix. Preimmune and found in rings, trophozoites, and schizonts, although activity immune sera were used to treat aliquots of the asynchronous appears highest in schizonts. In contrast, PfTopoI protein parasite extract before they were used in the standard relaxwas barely detectable immunologically in rings, although ation assay. The results of a typical experiment are shown higher, similar levels were found in trophozoite and schizont in Fig. 6 . Untreated extract almost completely relaxed the extracts. PfTOP1 message levels were found to be very low plasmid DNA and treatment with the preimmune serum had in both rings and schizonts but abundant in trophozoites. no effect on this activity. The immune antiserum, however, Finally, nuclear run-on experiments showed that the PfTOP1 completely inhibited the relaxation activity of the extract.
promoter only becomes active in the later stages of We believe this to be the result of immunodepletion of the development. extract but as yet have no direct evidence that it occurs.
Since TopoI is implicated in transcription and DNA replication, and since transcription takes place in all stages of intraerythrocytic development, it is not surprising to find some TopoI activity in extracts derived from each of the three DISCUSSION phases selected for study. However, activity is significantly greater in schizonts than in either rings or trophozoites, which may reflect a greater requirement for the enzyme at We have followed the expression of the gene encoding the time of DNA replication. the TopoI of P. falciparum by monitoring (a) its promoter
The protein itself is barely detectable immunologically in activity (b), the accumulation of PfTOP1 message, and (c) ring stage parasites but is found at similar levels in trophozothe levels of the enzyme itself as the parasite progresses ites and schizonts. Evidence that the antiserum is detecting from rings through trophozoites to schizonts. We have also the parasite's TopoI is threefold. (a) The band recognised in Western blots of parasite extracts is the correct size; no corresponding band is detected by preimmune serum from the same rabbit. (b) The immune serum was able to recognise protein fragments containing the same antigenic region from the parasite when these were expressed in E. coli. (c) The immune, but not the preimmune, serum from the same rabbit inhibited the action of the enzyme in DNA relaxation assays. Together these observations support the view that the protein detected in the parasite extracts is indeed PfTopoI. Clearly caution must be used in interpreting these data, quantitatively based as they are on comparisons between equal numbers of parasites, but a marked increase in activity in schizonts, unaccompanied by corresponding increases in the amounts of PfTopoI, suggests that factors other than the amount of enzyme present are influencing the level of activity observed. Workers with other systems have shown TopoI activity to be affected by a number of different covalent posttranslational modifications, including phosphorylation, ADP ribosylation, and, of course, proteolysis (Tricoli and Kowalski 1983; Durban et al. 1983; Ferro and Olivera 1984) . correlation between the level of phosphorylation and the activity of the protein. However, the contribution of phos-REFERENCES phorylation to the activity of the enzyme in the present example has still to be established and alternative explana- Bodley, A. L., Cumming, J. N., and Shapiro, T. A. 1998 able. This suggests that the protein is persistant in schizonts Bodley, A. L., Wani, M. C., Wall, M. E., and Shapiro, T. A. 1995. and is resistant to degradation. Indeed it is possible that Antitrypanosomal activity of camptothecin analogs: structure-activthe activity observed in the ring stage samples is activity ity correlations. Biochemical Pharmacology 50, 937-942. persisting from the preceeding cycle.
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Promoter activity, assayed using nuclear run-on, was ab-1987. DNA topoisomerase activity is required as a swivel for DNA sent from rings and appeared only at the later stages of replication and for ribosomal RNA transcription. In "NCI Monographs, Vol. 4, DNA Topoisomerases in Cancer Therapy," pp. 11-15. development. We were unable to separate trophozoites and schizonts for the purposes of assaying promoter activity but, 
